Atlas Trials

Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)

Clinical trial NCT03281083 · TERMINATED

Trial details

NCT number
NCT03281083
Sponsor
Duke-NUS Graduate Medical School
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Start date
2014-03-28
Primary completion
2016-07-28
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.